Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05952349Phase 2Completed
Phase 2, randomised, open-label trial (2 arms), sponsored by Khyber Medical University. Primary endpoints: Interleukin 6 at 3 months and Interleukin 8 at 3 months. Started Jul 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05952349.